3.2.4 Integrated service provision. Integrated service provision was considered innovative. Before providing integrated services, an analysis of the situation is carried out to find out who they are, where they are and why they are not vaccinated or are missing. The next step is to integrate immunization services with other programs such as the provision of vitamin A and malaria peanuts (insecticide-treated nets) to increase coverage, access and demand for immunization services with greater focus to remote rural areas, urban slums and hard-to-reach areas .3.2.5 Use of community health workers and non-health workers. The use of community health workers and non-health workers (influential people in the community) was considered innovative. In Burkina Faso, health workers and community representatives maintain lists of women and children in need of vaccinations, conduct house-to-house visits to identify eligible children, and refer them to the nearest health center or awareness sessions. Similarly, non-healthcare personnel are used to mobilize communities for immunization. Non-health personnel are also incorporated at the health center level with the establishment of the village health committee and the health center management committee (Comate de Gestion du Center de Santé). Non-health workers are the champions of immunization and other health services nationwide. community. They are used to identify children who are not immunized and this improves community participation in health services with the aim of comprehensive coverage of immunization services.3.2.6. Involvement of political and religious leaders. The involvement of political and religious leaders was one of the innovative aspects......halfway through the document......not funded by donors. The issue of future funding of the immunization program was, and still is, a growing concern for all stakeholders involved in the EPI (Eie, 2008). Donor dependency has an impact on the introduction of new vaccines such as hepatitis B, which have proven to be relatively expensive compared to basic antigens, suggesting that their introduction needs to be carefully planned and options such as phased introduction to Targeted regions or populations should be taken into consideration. MDG-4 will be missed unless local funding resources are harnessed and mobilized. It is also important to consider whether the introduction of a new vaccine will not negatively affect the use of the six traditional EPI antigens (Ministere de la santé Côte d'Ivoire 2007°). In Benin, Burkina Faso and Côte d'Ivoire, political will is needed to defeat infant mortality (Richard 2006).CH